0000899243-21-042213.txt : 20211101 0000899243-21-042213.hdr.sgml : 20211101 20211101192059 ACCESSION NUMBER: 0000899243-21-042213 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211031 FILED AS OF DATE: 20211101 DATE AS OF CHANGE: 20211101 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Larson Yi CENTRAL INDEX KEY: 0001785987 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40947 FILM NUMBER: 211368750 MAIL ADDRESS: STREET 1: C/O TURNING POINT THERAPEUTICS, INC. STREET 2: 10628 SCIENCE CENTER DRIVE, STE. 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LianBio CENTRAL INDEX KEY: 0001831283 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 BUSINESS ADDRESS: STREET 1: C/O OGIER GLOBAL (CAYMAN) LIMITED STREET 2: 89 NEXUS WAY, CAMANA BAY CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-9009 BUSINESS PHONE: 1 345 949 9876 MAIL ADDRESS: STREET 1: C/O OGIER GLOBAL (CAYMAN) LIMITED STREET 2: 89 NEXUS WAY, CAMANA BAY CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-9009 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-10-31 0 0001831283 LianBio LIAN 0001785987 Larson Yi C/O LIANBIO 103 CARNEGIE CENTER DRIVE, SUITE 215 PRINCETON NJ 08540 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 16.00 2021-10-31 4 A 0 229538 0.00 A 2031-10-31 Ordinary Shares 229538 1196845 D 25% of the shares underlying the option shall vest and become exercisable on October 31, 2022; the remainder shall vest and become exercisable in three equal annual installments such that the option shall be fully vested on October 31, 2025, subject to the Reporting Person providing continuous service to the Issuer on each such date. By: /s/ Angela Chen, Attorney-in-Fact 2021-11-01